Company Regen BioPharma Inc OTC Bulletin Board
Equities
US75886M1027
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Regenerative Medical Applications
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 29,338 | 0 | 0 | 99.99 % |
Stock B | 0 | 34 | 0 | 0 | |
Stock C | 1 | 4,114,622 | 4,114,118 ( 99.99 %) | 0 | |
Stock D | 0 | 409,551 | 0 | 0 |
Company contact information
Regen Biopharma, Inc.
4700 Spring Street Suite 304
91942, La Mesa
+619 722 5505
http://www.regenbiopharmainc.comSector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |